Pro-inflammatory cytokine expression occurs for a prolonged time in patients with COVID-19 at similar levels with influenza patients (1), with interleukin (IL)-6 and IL-10 (12–14) associated with increased COVID-19 severity, while it has been observed that the presence of antibodies, CD4+ and CD8+ T cells are correlated with a positive patient outcome (15). This evidence concerns the gene CD4 and COVID-19.